MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Return
46.22%
This Quarter Return
+10.61%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$20.7B
AUM Growth
+$3.14B
(+18%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
1,778
New
497
Increased
377
Reduced
371
Closed
524
Top Buys
| 1 |
HCA Healthcare
HCA
|
+$243M |
| 2 |
GoDaddy
GDDY
|
+$164M |
| 3 |
Cigna
CI
|
+$151M |
| 4 |
Pfizer
PFE
|
+$138M |
| 5 |
Hologic
HOLX
|
+$103M |
Top Sells
| 1 |
Apple
AAPL
|
+$169M |
| 2 |
Gilead Sciences
GILD
|
+$156M |
| 3 |
Microsoft
MSFT
|
+$135M |
| 4 |
McDonald's
MCD
|
+$121M |
| 5 |
Danaher
DHR
|
+$115M |
Sector Composition
| 1 | Healthcare | 25.95% |
| 2 | Technology | 21.4% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 11.77% |
| 5 | Financials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Herc Holdings
HRI
$4.29B
| $249K | ﹤0.01% |
5,090
-9,719
| -66% | -$475K |
|
|
KEM
927
DELISTED
KEMET Corporation
KEM
| $248K | ﹤0.01% |
9,174
-105,386
| -92% | -$2.85M |
|
928
Morningstar
MORN
$10.8B
| $246K | ﹤0.01% |
+1,624
| New | +$246K |
|
929
Iovance Biotherapeutics
IOVA
$876M
| $245K | ﹤0.01% |
+8,848
| New | +$245K |
|
930
Mercer International
MERC
$209M
| $243K | ﹤0.01% |
+19,785
| New | +$243K |
|
931
WhiteHorse Finance
WHF
$204M
| $243K | ﹤0.01% |
+17,706
| New | +$243K |
|
932
Howard Hughes
HHH
$4.85B
| $242K | ﹤0.01% |
+2,008
| New | +$242K |
|
933
PLDT
PHI
$4.24B
| $242K | ﹤0.01% |
12,066
-22,253
| -65% | -$446K |
|
|
ATRS
934
DELISTED
Antares Pharma, Inc.
ATRS
| $242K | ﹤0.01% |
51,487
+33,312
| +183% | +$157K |
|
|
GTT
935
DELISTED
GTT Communications, Inc.
GTT
| $241K | ﹤0.01% |
+21,272
| New | +$241K |
|
936
Banco Bradesco
BBD
$33.4B
| $238K | ﹤0.01% |
+35,343
| New | +$238K |
|
937
Ionis Pharmaceuticals
IONS
$10.2B
| $238K | ﹤0.01% |
3,939
-111,832
| -97% | -$6.76M |
|
938
Dorian LPG
LPG
$1.35B
| $238K | ﹤0.01% |
+15,410
| New | +$238K |
|
939
McKesson
MCK
$89.5B
| $238K | ﹤0.01% |
+1,725
| New | +$238K |
|
940
Amneal Pharmaceuticals
AMRX
$3.17B
| $237K | ﹤0.01% |
+49,021
| New | +$237K |
|
941
Conduent
CNDT
$458M
| $237K | ﹤0.01% |
+38,205
| New | +$237K |
|
942
TrueCar
TRUE
$199M
| $236K | ﹤0.01% |
+49,749
| New | +$236K |
|
943
Blackrock
BLK
$176B
| $233K | ﹤0.01% |
462
-663
| -59% | -$334K |
|
944
Dick's Sporting Goods
DKS
$20.7B
| $230K | ﹤0.01% |
+4,656
| New | +$230K |
|
945
Insmed
INSM
$30.8B
| $228K | ﹤0.01% |
9,539
-29,176
| -75% | -$697K |
|
946
US Physical Therapy
USPH
$1.25B
| $227K | ﹤0.01% |
+1,989
| New | +$227K |
|
|
CIT
947
DELISTED
CIT Group Inc.
CIT
| $227K | ﹤0.01% |
4,970
-290,046
| -98% | -$13.2M |
|
948
Franklin Covey
FC
$246M
| $226K | ﹤0.01% |
+7,011
| New | +$226K |
|
949
Denny's
DENN
$270M
| $225K | ﹤0.01% |
+11,329
| New | +$225K |
|
950
Live Oak Bancshares
LOB
$1.69B
| $225K | ﹤0.01% |
+11,859
| New | +$225K |
|